Then, in June 2026, HHS announced that FDA had concluded the age-related limitation was no longer warranted and requested it be removed from labeling - a change that may not yet appear on every product's current label
Both versions have been found to be equally efficient in managing generalized anxiety disorder (source)
Patients commonly experience neurocognitive deficits such as reduced working memory, slower processing speed and impaired executive function, together with affective symptoms including depression, apathy and anxiety, which heighten the overall neuropsychiatric burden (69, 70)
If BCBS denies coverage of Zepbound, even after your healthcare provider provides evidence of medical necessity, consider calling your insurer directly and asking for a case manager
The mTOR pathway plays a central role in cell growth, proliferation, and metabolism